LiteFold/IEDB huggingface dataset:
Reference: Haiqiang Yang; Jessica Cao; Xiaoyang Lin; Jingwen Yue; Tarek Zieneldien; Janice Kim; Lianchun Wang; Jianmin Fang; Ruo-Pan Huang; Yun Bai; Kevin Sneed; Chuanhai Cao. "Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models." Viruses (2022).

Epitope: J1
Chemical type: Peptide from protein
Sequence: YNYLYRLFRKSNLKPFERDISTEIYQA
Position: 449-475
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Positive-Low

Epitope: J1
Chemical type: Peptide from protein
Sequence: YNYLYRLFRKSNLKPFERDISTEIYQA
Position: 449-475
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Positive-Low

Epitope: J1
Chemical type: Peptide from protein
Sequence: YNYLYRLFRKSNLKPFERDISTEIYQA
Position: 449-475
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Positive-Low
Host:  6 months

Epitope: C2
Chemical type: Peptide from protein
Sequence: NSAIGKIQDSLSSTASAL
Position: 928-945
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Negative

Epitope: C2
Chemical type: Peptide from protein
Sequence: NSAIGKIQDSLSSTASAL
Position: 928-945
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Negative

Epitope: C2
Chemical type: Peptide from protein
Sequence: NSAIGKIQDSLSSTASAL
Position: 928-945
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Negative
Host:  6 months

Epitope: F2
Chemical type: Peptide from protein
Sequence: MTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGV
Position: 1237-1268
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Positive

Epitope: F2
Chemical type: Peptide from protein
Sequence: MTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGV
Position: 1237-1268
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Positive

Epitope: F2
Chemical type: Peptide from protein
Sequence: MTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGV
Position: 1237-1268
Source molecule (GenBank): YP_009724390.1
Assay category: BCell
Result: Positive-Low
Host:  6 months
Reference: Antonio Abad-Fuentes; Consuelo Agulló; Daniel López-Puertollano; Ismael Navarro-Fuertes; Antonio Abad-Somovilla; Josep Vicent Mercader. "Alternative Hapten Design for Zearalenone Immunoreagent Generation." Toxins (2022).

Epitope: alpha-zearalenol (alpha-ZEL)
Chemical type: Other Non-Sequence
Assay category: BCell
Result: Positive
Host: F

Epitope: alpha-zearalenol (alpha-ZEL)
Chemical type: Other Non-Sequence
Assay category: BCell
Result: Positive-Low
Host: F
Reference: Yingze Zhao; Mingwei Sun; Nan Zhang; Xueyuan Liu; Can Yue; Lei Feng; Shushen Ji; Xiao Liu; Jianxun Qi; Catherine C L Wong; George F Gao; William J Liu. "Phosphosite-dependent presentation of dual phosphorylated peptides by MHC class I molecules." iScience (2022).

Epitope: Monop-RR10
Chemical type: Peptide from protein
Sequence: RRFSRSPIRR
Position: 2026-2035
Source molecule (GenBank): P18583.4
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 1.81

Epitope: Monop-RR10
Chemical type: Peptide from protein
Sequence: RRFSRSPIRR
Position: 2026-2035
Source molecule (GenBank): P18583.4
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 64.3
Reference: Tao Chen; Ruiqi Hu; Ying Wan; Fengzeng Sun; Zichen Wang; Junqiu Yue; Jian Chen; Guang Han; Guangwei Wei; Zhiqiang Dong. "Comprehensive mutanome analysis of Lewis lung cancer reveals immunogenic neoantigens for therapeutic vaccines." Biochemical and biophysical research communications (2020).

Epitope: Mut 4
Chemical type: Peptide, no natural source
Sequence: KKHKKEKAVSIATPATAAPAAVSA
Assay category: TCell
Result: Negative
Host: M 
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: Mut 4
Chemical type: Peptide, no natural source
Sequence: KKHKKEKAVSIATPATAAPAAVSA
Assay category: TCell
Result: Negative
Host: M 
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: Mut 9
Chemical type: Peptide, no natural source
Sequence: GPQAISKATFETLAADPTPAATIV
Assay category: TCell
Result: Negative
Host: M 
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: Mut 9
Chemical type: Peptide, no natural source
Sequence: GPQAISKATFETLAADPTPAATIV
Assay category: TCell
Result: Negative
Host: M 
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Franziska Blaeschke; Milan Cedric Paul; Martin Ulrich Schuhmann; Armin Rabsteyn; Christopher Schroeder; Nicolas Casadei; Jakob Matthes; Christopher Mohr; Ramin Lotfi; Beate Wagner; Theresa Kaeuferle; Judith Feucht; Semjon Willier; Rupert Handgretinger; Stefan StevanoviĆ; Peter Lang; Tobias Feuchtinger. "Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy." Cytotherapy (2019).

Epitope: PDCD10 P1
Chemical type: Peptide, no natural source
Sequence: IASPIKEL
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: PDCD10 P1
Chemical type: Peptide, no natural source
Sequence: IASPIKEL
Assay category: TCell
Result: Negative
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: INSM1
Chemical type: Peptide, no natural source
Sequence: YADPFALV
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: INSM1
Chemical type: Peptide, no natural source
Sequence: YADPFALV
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: RNF165
Chemical type: Peptide, no natural source
Sequence: MVVHEIQNY
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: RNF165
Chemical type: Peptide, no natural source
Sequence: MVVHEIQNY
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Edurne Rujas; Iga Kucharska; Yong Zi Tan; Samir Benlekbir; Hong Cui; Tiantian Zhao; Gregory A Wasney; Patrick Budylowski; Furkan Guvenc; Jocelyn C Newton; Taylor Sicard; Anthony Semesi; Krithika Muthuraman; Amy Nouanesengsy; Clare Burn Aschner; Katherine Prieto; Stephanie A Bueler; Sawsan Youssef; Sindy Liao-Chan; Jacob Glanville; Natasha Christie-Holmes; Samira Mubareka; Scott D Gray-Owen; John L Rubinstein; Bebhinn Treanor; Jean-Philippe Julien. "Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers." Nature communications (2021).

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive
Quantitative measurement: 2.95

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive
Quantitative measurement: 24.0

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 298 Fab on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: F456, Q474, A475, G476, S477, T478, E484, G485, F486, N487, Y489, Q493
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive
Reference: Ruoke Wang; Qi Zhang; Jiwan Ge; Wenlin Ren; Rui Zhang; Jun Lan; Bin Ju; Bin Su; Fengting Yu; Peng Chen; Huiyu Liao; Yingmei Feng; Xuemei Li; Xuanling Shi; Zheng Zhang; Fujie Zhang; Qiang Ding; Tong Zhang; Xinquan Wang; Linqi Zhang. "Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species." Immunity (2021).

Epitope: SARS-CoV-2 S 242-244del
Chemical type: Discontinuous protein residues
Discontinuous residues: L242, A243, L244
Source molecule (GenBank): QHD43416.1
Assay category: BCell
Result: Positive
Host:  29-81 years

Epitope: Epitope of P5A-1B9 on SARS-CoV-2
Chemical type: Discontinuous protein residues
Discontinuous residues: G446, N448, Y449, L452, E484, G485, F486, N487, Y489, F490, L492, Q493, S494
Source molecule (GenBank): QHD43416.1
Assay category: BCell
Result: Positive
Host:  10-66 years

Epitope: Epitope of P5A-1B9 on SARS-CoV-2
Chemical type: Discontinuous protein residues
Discontinuous residues: G446, N448, Y449, L452, E484, G485, F486, N487, Y489, F490, L492, Q493, S494
Source molecule (GenBank): QHD43416.1
Assay category: BCell
Result: Positive
Host:  10-66 years

Epitope: Epitope of P5A-1B9 on SARS-CoV-2
Chemical type: Discontinuous protein residues
Discontinuous residues: G446, N448, Y449, L452, E484, G485, F486, N487, Y489, F490, L492, Q493, S494
Source molecule (GenBank): QHD43416.1
Assay category: BCell
Result: Positive
Host:  10-66 years

Epitope: Epitope of P5A-1B9 on SARS-CoV-2
Chemical type: Discontinuous protein residues
Discontinuous residues: G446, N448, Y449, L452, E484, G485, F486, N487, Y489, F490, L492, Q493, S494
Source molecule (GenBank): QHD43416.1
Assay category: BCell
Result: Positive
Host:  10-66 years

Epitope: Epitope of P5A-1B9 on SARS-CoV-2
Chemical type: Discontinuous protein residues
Discontinuous residues: G446, N448, Y449, L452, E484, G485, F486, N487, Y489, F490, L492, Q493, S494
Source molecule (GenBank): QHD43416.1
Assay category: BCell
Result: Positive
Quantitative measurement: 1.7
Host:  10-66 years
Reference: Masanori Noguchi; Fukuko Moriya; Shigetaka Suekane; Kei Matsuoka; Gaku Arai; Satoko Matsueda; Tetsuro Sasada; Akira Yamada; Kyogo Itoh. "Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy." The Prostate (2012).

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: BCell
Result: Positive
Host: M 53-81 years

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: BCell
Result: Positive
Host: M 53-81 years

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: TCell
Result: Negative
Host: M 53-81 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: TCell
Result: Negative
Host: M 53-81 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: TCell
Result: Negative
Host: M 53-81 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: TCell
Result: Negative
Host: M 53-81 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: TCell
Result: Positive
Host: M 53-81 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: SART3-109
Chemical type: Peptide from protein
Sequence: VYDYNCHVDL
Position: 109-118
Source molecule (GenBank): Q15020.1
Assay category: TCell
Result: Negative
Host: M 53-81 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Ana Tajuelo; Mireia López-Siles; Vicente Más; Pilar Pérez-Romero; José María Aguado; Verónica Briz; Michael J McConnell; Antonio J Martín-Galiano; Daniel López. "Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins." International journal of molecular sciences (2022).

Epitope: Exc-1 N-Ep1 Nucleoprotein 66-74
Chemical type: Peptide from protein
Sequence: FPDGQGVPI
Position: 79-87
Source molecule (GenBank): AMM42379.1
Assay category: BCell
Result: Positive-Low

Epitope: Exc-1 N-Ep1 Nucleoprotein 66-74
Chemical type: Peptide from protein
Sequence: FPDGQGVPI
Position: 79-87
Source molecule (GenBank): AMM42379.1
Assay category: BCell
Result: Positive-Low

Epitope: Exc-1 N-Ep4 Nucleoprotein 257-265
Chemical type: Peptide from protein
Sequence: KPRQKRTAN
Position: 257-265
Source molecule (GenBank): QWT61685.1
Assay category: BCell
Result: Positive-Low

Epitope: Exc-1 N-Ep4 Nucleoprotein 257-265
Chemical type: Peptide from protein
Sequence: KPRQKRTAN
Position: 257-265
Source molecule (GenBank): QWT61685.1
Assay category: BCell
Result: Positive
Reference: Miranda H Meeuwsen; Anne K Wouters; Renate S Hagedoorn; Michel G D Kester; Dennis F G Remst; Dirk M van der Steen; Arnoud de Ru; Peter A van Veelen; Jamie Rossjohn; Stephanie Gras; J H Frederik Falkenburg; Mirjam H M Heemskerk. "Cutting Edge: Unconventional CD8<sup>+</sup> T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope." Journal of immunology (Baltimore, Md. : 1950) (2022).

Epitope: FLP 17 mer_IL-27R7α 617-633
Chemical type: Peptide from protein
Sequence: FLPTPEELGLLGPPRPQ
Position: 617-633
Source molecule (GenBank): Q6UWB1.2
Assay category: MhcLigandElution
Result: Negative

Epitope: FLP 14 mer_IL-27R7α 617-630
Chemical type: Peptide from protein
Sequence: FLPTPEELGLLGPP
Position: 617-630
Source molecule (GenBank): Q6UWB1.2
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: FLP 14 mer_IL-27R7α 617-630
Chemical type: Peptide from protein
Sequence: FLPTPEELGLLGPP
Position: 617-630
Source molecule (GenBank): Q6UWB1.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: FLP 14 mer_IL-27R7α 617-630
Chemical type: Peptide from protein
Sequence: FLPTPEELGLLGPP
Position: 617-630
Source molecule (GenBank): Q6UWB1.2
Assay category: MhcLigandElution
Result: Negative

Epitope: FLP 13 mer_IL-27Rα 617-629
Chemical type: Peptide from protein
Sequence: FLPTPEELGLLGP
Position: 617-629
Source molecule (GenBank): Q6UWB1.2
Assay category: MhcLigandElution
Result: Positive

Epitope: FLP 10 mer_IL-27R7α 617-626
Chemical type: Peptide from protein
Sequence: FLPTPEELGL
Position: 617-626
Source molecule (GenBank): Q6UWB1.2
Assay category: MhcLigandElution
Result: Negative
Reference: Sylwia Osuch; Tomasz Laskus; Karol Perlejewski; Hanna Berak; Iwona Bukowska-Ośko; Agnieszka Pollak; Magdalena Zielenkiewicz; Marek Radkowski; Kamila Caraballo Cortés. "CD8<sup>+</sup> T-Cell Exhaustion Phenotype in Chronic Hepatitis C Virus Infection Is Associated With Epitope Sequence Variation." Frontiers in immunology (2022).

Epitope: HCV-NS3-1406
Chemical type: Peptide from protein
Sequence: KLSGLGLNAV
Position: 1406-1415
Source molecule (GenBank): ACE82442.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Mirosława Panasiuk; Karolina Zimmer; Anna Czarnota; Magdalena Narajczyk; Grażyna Peszyńska-Sularz; Milena Chraniuk; Lilit Hovhannisyan; Sabina Żołędowska; Dawid Nidzworski; Anna J Żaczek; Beata Gromadzka. "Chimeric virus-like particles presenting tumour-associated MUC1 epitope result in high titers of specific IgG antibodies in the presence of squalene oil-in-water adjuvant: towards safe cancer immunotherapy." Journal of nanobiotechnology (2022).

Epitope: Mucin-1 142-161
Chemical type: Peptide from protein
Sequence: PDTRPAPGSTAPPAHGVTSA
Position: 142-161
Source molecule (GenBank): P15941.3
Assay category: BCell
Result: Positive-High
Host: M 6 weeks

Epitope: Mucin-1 142-161
Chemical type: Peptide from protein
Sequence: PDTRPAPGSTAPPAHGVTSA
Position: 142-161
Source molecule (GenBank): P15941.3
Assay category: BCell
Result: Negative
Host: M 6 weeks

Epitope: Mucin-1 142-161
Chemical type: Peptide from protein
Sequence: PDTRPAPGSTAPPAHGVTSA
Position: 142-161
Source molecule (GenBank): P15941.3
Assay category: BCell
Result: Positive-Intermediate
Host: M 6 weeks

Epitope: Mucin-1 142-161
Chemical type: Peptide from protein
Sequence: PDTRPAPGSTAPPAHGVTSA
Position: 142-161
Source molecule (GenBank): P15941.3
Assay category: BCell
Result: Positive-Low
Host: M 6 weeks

Epitope: Mucin-1 142-161
Chemical type: Peptide from protein
Sequence: PDTRPAPGSTAPPAHGVTSA
Position: 142-161
Source molecule (GenBank): P15941.3
Assay category: BCell
Result: Positive
Reference: John C Flickinger; Jagmohan Singh; Yanki Yarman; Robert D Carlson; Joshua R Barton; Scott A Waldman; Adam E Snook. "T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C." Frontiers in immunology (2022).

Epitope: GUCY2C 254-262 L262I
Chemical type: Peptide, no natural source
Sequence: SFYDVKGDI
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: GUCY2C 254-262 L262I
Chemical type: Peptide, no natural source
Sequence: SFYDVKGDI
Assay category: MhcBinding
Result: Positive-Low
Quantitative measurement: 60.0
Reference: Federico Ballabio; Luca Broggini; Cristina Paissoni; Xiao Han; Kaliroi Peqini; Benedetta Maria Sala; Renhua Sun; Tatyana Sandalova; Alberto Barbiroli; Adnane Achour; Sara Pellegrino; Stefano Ricagno; Carlo Camilloni. "l- to d-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics." ACS omega (2022).

Epitope: gp33-F6f (KAVYNfATM)
Chemical type: Peptide, no natural source
Sequence: KAVYNFATM
Assay category: TCell
Result: Positive
Quantitative measurement: 70000.0

Epitope: gp33-F6f (KAVYNfATM)
Chemical type: Peptide, no natural source
Sequence: KAVYNFATM
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 61.5

Epitope: gp33-F6f (KAVYNfATM)
Chemical type: Peptide, no natural source
Sequence: KAVYNFATM
Assay category: MhcBinding
Result: Positive
Quantitative measurement: 2.6
Reference: Chang Liu; Helen M Ginn; Wanwisa Dejnirattisai; Piyada Supasa; Beibei Wang; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Daming Zhou; Alexander J Mentzer; Yuguang Zhao; Helen M E Duyvesteyn; César López-Camacho; Jose Slon-Campos; Thomas S Walter; Donal Skelly; Sile Ann Johnson; Thomas G Ritter; Chris Mason; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Christina Dold; Nigel Temperton; Tao Dong; Andrew J Pollard; Julian C Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C Gilbert; Tariq Malik; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Vicky Baillie; Natali Serafin; Zanele Ditse; Kelly Da Silva; Neil G Paterson; Mark A Williams; David R Hall; Shabir Madhi; Marta C Nunes; Philip Goulder; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton. "Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum." Cell (2021).

Epitope: Epitope of S309 on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: N331, I332, T333, N334, L335, P337, G339, E340, N343, A344, T345, R346, K356, R357, S359, C361, L441
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of S309 on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: N331, I332, T333, N334, L335, P337, G339, E340, N343, A344, T345, R346, K356, R357, S359, C361, L441
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive

Epitope: Epitope of S309 on SARS-CoV-2 RBD
Chemical type: Discontinuous protein residues
Discontinuous residues: N331, I332, T333, N334, L335, P337, G339, E340, N343, A344, T345, R346, K356, R357, S359, C361, L441
Source molecule (GenBank): P0DTC2.1
Assay category: BCell
Result: Positive
Reference: Yasuto Akiyama; Masaru Komiyama; Yoji Nakamura; Akira Iizuka; Chie Oshita; Akiko Kume; Masahiro Nogami; Haruo Miyata; Tadashi Ashizawa; Shusuke Yoshikawa; Yoshio Kiyohara; Ken Yamaguchi. "Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay." Cancer immunology, immunotherapy : CII (2012).

Epitope: MAGE-A6-4
Chemical type: Peptide from protein
Sequence: IFGDPKKLL
Position: 238-246
Source molecule (GenBank): P43360.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MAGE-A6-4
Chemical type: Peptide from protein
Sequence: IFGDPKKLL
Position: 238-246
Source molecule (GenBank): P43360.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: MAGE-A6-4
Chemical type: Peptide from protein
Sequence: IFGDPKKLL
Position: 238-246
Source molecule (GenBank): P43360.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: MAGE-A6-4
Chemical type: Peptide from protein
Sequence: IFGDPKKLL
Position: 238-246
Source molecule (GenBank): P43360.1
Assay category: MhcBinding
Result: Positive-Intermediate
Reference: Yoshitaka Shirakura; Yukari Mizuno; Linan Wang; Naoko Imai; Chisaki Amaike; Eiichi Sato; Mamoru Ito; Ikuei Nukaya; Junichi Mineno; Kazutoh Takesako; Hiroaki Ikeda; Hiroshi Shiku. "T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice." Cancer science (2012).

Epitope: MAGE-A4 143-151
Chemical type: Peptide from protein
Sequence: NYKRCFPVI
Position: 143-151
Source molecule (GenBank): C9JZJ5.9
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: MAGE-A4 143-151
Chemical type: Peptide from protein
Sequence: NYKRCFPVI
Position: 143-151
Source molecule (GenBank): C9JZJ5.9
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: MAGE-A4 143-151
Chemical type: Peptide from protein
Sequence: NYKRCFPVI
Position: 143-151
Source molecule (GenBank): C9JZJ5.9
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered